O P Singh (Cadila Pharma)

We at Cadila Pharmaceuticals Ltd are pleased to know that SMSRC is celebrating 10th Anniversary. Our heartiest congratulations to you and your team. Your team’s contributions to Indian Pharma Industry through market intelligence with the help of Rx audit is truly path breaking and immensely valuable. I am particularly pleased with SMSRC’s association with Cadila Pharma over the years and the market intelligence provided through SPR. We always look forward to your quarterly presentations at our Corporate Office through which we gain immense insights and reality check on strategic alignment of our internal marketing strategies. We also appreciate your proactive and foresighted approach in coming prepared with new ways of presenting the data which is more appropriate and relevant to the situation. We always consider SMSRC as a key partner while making important decisions related to portfolio / therapy gap assessment. At this juncture, when the Rx oriented pharma business is faced with multiple challenges including the penetration of new technology solutions, SMSRC’s contributions will be much more relevant and wanted for sustenance of the growth. We wish Team SMSRC all the very best in coming out with new and updated solutions that can offer specific insights for sustainable growth of our business. Once again, please accept my sincere compliments and best wishes for continuing success in all your endeavours.